![Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient - Riccardo Sarzani, Giorgia Laureti, Alessandro Gezzi, Francesco Spannella, Federico Giulietti, 2022 Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient - Riccardo Sarzani, Giorgia Laureti, Alessandro Gezzi, Francesco Spannella, Federico Giulietti, 2022](https://journals.sagepub.com/cms/10.1177/20406223221102754/asset/images/large/10.1177_20406223221102754-fig2.jpeg)
Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient - Riccardo Sarzani, Giorgia Laureti, Alessandro Gezzi, Francesco Spannella, Federico Giulietti, 2022
![A Modern Perspective on β‐Blocker Use in Hypertension: Clinical Trials and Their Influence on Clinical Practice - Black - 2007 - The Journal of Clinical Hypertension - Wiley Online Library A Modern Perspective on β‐Blocker Use in Hypertension: Clinical Trials and Their Influence on Clinical Practice - Black - 2007 - The Journal of Clinical Hypertension - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/eea29a47-d968-4f35-876a-046a67dd222c/jch_6652_f1.jpg)
A Modern Perspective on β‐Blocker Use in Hypertension: Clinical Trials and Their Influence on Clinical Practice - Black - 2007 - The Journal of Clinical Hypertension - Wiley Online Library
![Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study | The BMJ Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study | The BMJ](https://www.bmj.com/content/bmj/347/bmj.f6745/F1.large.jpg)
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study | The BMJ
![Risk/Benefit Assessment of β-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension | Circulation Risk/Benefit Assessment of β-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension | Circulation](https://www.ahajournals.org/cms/asset/fa72a5ef-6a9f-400a-8569-c64940345c72/24ff6.jpeg)
Risk/Benefit Assessment of β-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension | Circulation
![IJERPH | Free Full-Text | Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development IJERPH | Free Full-Text | Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development](https://pub.mdpi-res.com/ijerph/ijerph-19-04156/article_deploy/html/images/ijerph-19-04156-g001.png?1648881271)
IJERPH | Free Full-Text | Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development
Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic - Document - Gale OneFile: Health and Medicine
![SciELO - Brasil - I Posicionamento Brasileiro sobre Combinação de Fármacos Anti-Hipertensivos I Posicionamento Brasileiro sobre Combinação de Fármacos Anti-Hipertensivos SciELO - Brasil - I Posicionamento Brasileiro sobre Combinação de Fármacos Anti-Hipertensivos I Posicionamento Brasileiro sobre Combinação de Fármacos Anti-Hipertensivos](https://minio.scielo.br/documentstore/1678-4170/f5vmjYGcVcqxv5QNDLg8TqK/a02955237011a065f961519cd521b05100669d55.jpg)
SciELO - Brasil - I Posicionamento Brasileiro sobre Combinação de Fármacos Anti-Hipertensivos I Posicionamento Brasileiro sobre Combinação de Fármacos Anti-Hipertensivos
![Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and Hypertension | Hypertension Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and Hypertension | Hypertension](https://www.ahajournals.org/cms/asset/742cec22-824d-4dc8-85cf-26aafbe36276/hypertensionaha.120.16263.fig04.jpg)
Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and Hypertension | Hypertension
![Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fhr.2014.130/MediaObjects/41440_2014_Article_BFhr2014130_Fig1_HTML.jpg)
Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research
![Thiazide-Type Diuretics and β-Adrenergic Blockers as First-Line Drug Treatments for Hypertension | Circulation Thiazide-Type Diuretics and β-Adrenergic Blockers as First-Line Drug Treatments for Hypertension | Circulation](https://www.ahajournals.org/cms/asset/727d584d-0dc0-4010-aaea-5b0a0ef2c8b2/23ff7.jpeg)
Thiazide-Type Diuretics and β-Adrenergic Blockers as First-Line Drug Treatments for Hypertension | Circulation
![PDF] Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease | Semantic Scholar PDF] Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c69e29213900f84a2ad7466adc1a44f712cdf4d9/6-Table2-1.png)